Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11)
IFN-β : All interferons are approved for the treatment of RRMS, moreover Betaferon and Avonex are also approved for the treatment of clinical isolated syndrome (CIS) and Betaferon for the treatment of active secondary progressive MS (SPMS) as well (EMA website). Long-term data regarding safety and e...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Iran University of Medical Sciences
2023-01-01
|
| Series: | Neurology Letters |
| Subjects: | |
| Online Access: | https://www.neurologyletters.com/article_184160_d41d8cd98f00b204e9800998ecf8427e.pdf |